Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Net Income
Bottom-line profit after all expenses, interest, and taxes.
Net Income history
Currency unavailable · from the income statement
No Net Income data reported for this period type.
Net Income vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -$6.29M USD | -186.7% | +29.7% | 5.4% | |
| LTM Mar 2026 | -$23.91M USD | -179.4% | — | 6.6% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | -SEK 272.5M SEK | +7.2% | — | 20489.5% |
| LTM Jun 2026 | -$875.31M USD | +15.4% | — | 76.9% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -86.1% | +29.7% | 41.8% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.